Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 552 participants.
Also called NCT01630369
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 552 participants
- Sponsor
- Registry
-
NCT01630369
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Ukraine
- Registry status
- Completed
Technical summary
Registry record NCT01630369. Non-randomized; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes
- Acronym
- SPIRIT
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- insulin human (HR1799)
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01630369- Content hash
8ee693be7922c895961f0d15253341cdf2092eba7f1b80471d64bbf2ca53059c